Rebecca Araujo

DocwireNews

This week on DocWire, editors spoke with Dr. Nikhil Munshi, of the Dana-Farber Cancer Institute, about why treatment sequencing and selection is a <a href="https://www.docwirenews.com/condition-center/multiple-myeloma-knowledge-hub/multiple-myeloma-kol-video/multiple-myeloma-treatment-sequencing-and-selection-with-dr-nikhil-munshi/">complex issue in multiple myeloma</a>. &ldquo;With 13, 14 drugs available, there are permutations and combinations that one can utilize,&rdquo; said Dr. Munshi. &ldquo;And selecting them in the right sequence, and compressing various patient features, disease features, etc., brings about the complexity.&rdquo;https://www.docwirenews.com/condition-center/multiple-myeloma-knowledge-hub/multiple-myeloma-kol-video/multiple-myeloma-treatment-sequencing-and-selection-with-dr-nikhil-munshi/&ndash; 
In other news, the U.S. Preventative Services Task Force updated their guidance on starting screening for colorectal cancer (CRC) to adults aged 45 years, down from the <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/uspstf-urges-crc-screening-for-adults-aged-50-to-75-45-to-49/">previous suggested age of 50 years</a>. The researchers found that lowering the age to begin screening from 50 to 45 years yielded 22 to 27 additional life-years gained per 1,000 persons. &ldquo;To encourage screening and help patients select the best test for them, we urge primary care clinicians to talk about the pros and cons of the various recommended options with their patients,&rdquo; a task force member said in a statement.https://www.docwirenews.com/docwire-pick/hem-onc-picks/uspstf-urges-crc-screening-for-adults-aged-50-to-75-45-to-49/&ndash; 
Researchers recently took a deeper dive into what young adults with cancer need most from those taking care of them by analyzing <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/young-women-with-cancer-share-their-real-lived-experiences-of-diagnosis-treatment-and-beyond/">blogs written by patients</a>. From their analyses of the blogs, two main themes emerged: interactions with healthcare personnel and living with their cancer diagnosis. Patients reported challenges obtaining information about their care or diagnosis, and alienating encounters with their providers. They also reported struggling with the physical and mental impact of their diagnosis, finding hope, and living with ongoing fear.https://www.docwirenews.com/docwire-pick/hem-onc-picks/young-women-with-cancer-share-their-real-lived-experiences-of-diagnosis-treatment-and-beyond/&ndash; 
Finally, a large-scale U.K. trial of ovarian cancer screening was <a href="https://www.docwirenews.com/hematology-oncology/large-scale-trial-of-ovarian-cancer-screening-fails-to-reduce-deaths/">unable to reduce deaths</a> from the disease, according to findings published in The Lancet. Researchers examined more than 200,000 women aged 50&ndash;74 who were randomly assigned to one of three groups: no screening, annual screening using an ultrasound scan, and annual multimodal screening involving a blood test followed by an ultrasound scan as a second line test. While multimodal testing succeeded at detecting early-stage cancer, neither screening method led to a reduction in deaths.https://www.docwirenews.com/hematology-oncology/large-scale-trial-of-ovarian-cancer-screening-fails-to-reduce-deaths/

Roger Rodby, MD

Joel M. Topf, MD, FACP

Seldin Award Winner Advocates Online Education

NKF Spring Clinical Meetings 2025

Hatem Soliman, MD

The Future of Dendritic Cell Vaccines in HER2+ Breast Cancer: Toward De-Escalation of Chemotherapy

HER2 Breast Cancer

Jordana Jampel

Mechanism of Positive Association Between Parkinson’s Disease and Melanoma Revealed in New Research

Melanoma

Latest News

Hem/Onc Roundup: Expert Discusses Myeloma Treatment Sequencing, Plus New CRC Screening Guidelines

Oncology

This week on DocWire, editors spoke with Dr. Nikhil Munshi, of the Dana-Farber Cancer Institute, about why treatment sequencing and selection is a complex issue in multiple ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe